Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
731K
-
Shares change
-
+510K
-
Total reported value, excl. options
-
$132M
-
Value change
-
+$91.9M
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$179.80
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2023
5 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2023.
REPLIGEN CORP - COMMON STOCK (RGEN) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 731K shares
of 56.2M outstanding shares and own 1.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.86M shares), VANGUARD GROUP INC (5.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.01M shares), FMR LLC (1.88M shares), STATE STREET CORP (1.7M shares), MACQUARIE GROUP LTD (1.57M shares), BROWN CAPITAL MANAGEMENT LLC (1.53M shares), Artisan Partners Limited Partnership (1.52M shares), SANDS CAPITAL MANAGEMENT, LLC (1.5M shares), and Bank of New York Mellon Corp (1.15M shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.